Insulin autoimmune syndrome (Hirata disease)
Hypoglycaemia · Endocrine
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Autoimmune hypoglycaemia from autoantibodies to insulin, causing post-absorptive hypoglycaemia with very high insulin levels; linked to certain drugs (sulfhydryl-containing) and autoimmune disease.
Red flags
- Severe or recurrent hypoglycaemia
- Reduced conscious level
- Seizures
- Failure of dietary measures
Assessment
Differential diagnosis
- Insulinoma
- Factitious insulin administration
- Sulfonylurea-induced hypoglycaemia
- Non-islet cell tumour hypoglycaemia
- Adrenal insufficiency
Investigations
- Glucose with paired insulin and C-peptide
- Insulin autoantibodies
- Drug history (recent sulfhydryl drugs)
- Screen for autoimmune disease
- Imaging only if insulinoma suspected
Management
- Treat acute hypoglycaemia
- Confirm hypoglycaemia with paired samples (very high insulin, high antibodies)
- Stop any implicated drug
- Small frequent low-carbohydrate meals to prevent episodes
- Corticosteroids for persistent cases (specialist)
- Endocrinology referral
Drugs & doses
IV / oral glucose acutely
Corticosteroids (specialist)
Discontinue offending drug
Disposition
Admit for control; endocrinology.
Complications & pitfalls
- Neuroglycopenic injury
- Recurrent hypoglycaemia
- Diagnostic confusion with insulinoma
Exam pearls
- Extremely high insulin with detectable antibodies distinguishes it from insulinoma.
- Often self-limiting once a triggering drug is stopped.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.